Dose-dense rituximab-CHOP compared with standard rituximab-CHOP in elderly patients with diffuse large B-cell lymphoma (the LNH03-6B study): a randomised phase 3 trial-Reference-Cited by-同舟云学术

Dose-dense rituximab-CHOP compared with standard rituximab-CHOP in elderly patients with diffuse large B-cell lymphoma (the LNH03-6B study): a randomised phase 3 trial

Published:2013-05 Issue:6 Volume:14 Page:525-533
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Delarue Richard,Tilly Hervé,Mounier Nicolas,Petrella Tony,Salles Gilles,Thieblemont Catherine,Bologna Serge,Ghesquières Hervé,Hacini Maya,Fruchart Christophe,Ysebaert Loïc,Fermé Christophe,Casasnovas Olivier,Van Hoof Achiel,Thyss Antoine,Delmer Alain,Fitoussi Olivier,Molina Thierry Jo,Haioun Corinne,Bosly André

Publisher

Elsevier BV

Subject

Oncology

Reference25 articles.

1. Lymphoma incidence patterns by WHO subtype in the United States, 1992–2001;Morton;Blood,2006

2. Introduction of combined CHOP plus rituximab therapy dramatically improved outcome of diffuse large B-cell lymphoma in British Columbia;Sehn;J Clin Oncol,2005

3. Anti-CD20 antibody therapy for B-cell lymphomas;Maloney;N Engl J Med,2012

4. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma;Coiffier;N Engl J Med,2002

5. Rituximab-CHOP versus CHOP alone or with maintenance rituximab in older patients with diffuse large B-cell lymphoma;Habermann;J Clin Oncol,2006

Cited by 251 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparative effectiveness of 6x R-CHOP21 versus 6x R-CHOP21 + 2 R for patients with advanced-stage diffuse large B-cell lymphoma;Blood Cancer Journal;2024-09-12

2. MYC Rearrangement Prediction from LYSA Whole Slide Images in Large B-cell Lymphoma: A Multi-centric Validation of Self-supervised Deep Learning Models;Modern Pathology;2024-09

3. Clinical outcomes of patients with newly diagnosed large B-cell lymphoma in a safety-net hospital system;Blood Neoplasia;2024-09

4. Identification, risk factors, and clinical course of CNS relapse in DLBCL patients across 19 prospective phase 2 and 3 trials—a LYSA and GLA/ DSHNHL collaboration;Leukemia;2024-08-16

5. Comparison of R‐CHOP‐14 and R‐mini‐CHOP in older adults with diffuse large B‐cell lymphoma—A retrospective multicenter cohort study;European Journal of Haematology;2024-07-31